author_facet Vilorio-Marqués, Laura
Martín, Vicente
Diez-Tascón, Cristina
González-Sevilla, María Francisca
Fernández-Villa, Tania
Honrado, Emiliano
Davila-Batista, Veronica
Molina, Antonio J.
Vilorio-Marqués, Laura
Martín, Vicente
Diez-Tascón, Cristina
González-Sevilla, María Francisca
Fernández-Villa, Tania
Honrado, Emiliano
Davila-Batista, Veronica
Molina, Antonio J.
author Vilorio-Marqués, Laura
Martín, Vicente
Diez-Tascón, Cristina
González-Sevilla, María Francisca
Fernández-Villa, Tania
Honrado, Emiliano
Davila-Batista, Veronica
Molina, Antonio J.
spellingShingle Vilorio-Marqués, Laura
Martín, Vicente
Diez-Tascón, Cristina
González-Sevilla, María Francisca
Fernández-Villa, Tania
Honrado, Emiliano
Davila-Batista, Veronica
Molina, Antonio J.
Scientific Reports
The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
Multidisciplinary
author_sort vilorio-marqués, laura
spelling Vilorio-Marqués, Laura Martín, Vicente Diez-Tascón, Cristina González-Sevilla, María Francisca Fernández-Villa, Tania Honrado, Emiliano Davila-Batista, Veronica Molina, Antonio J. 2045-2322 Springer Science and Business Media LLC Multidisciplinary http://dx.doi.org/10.1038/s41598-017-13670-z <jats:title>Abstract</jats:title><jats:p>Enhancer of zeste homolog 2 (EZH2) is the catalitic subunit of polycomb repressive complex 2 and mediates gene silencing. EZH2 is overexpressed in many cancers and correlates with poor prognosis. The role of the gene EZH2 in colorectal cancer survival is uncertainly, the aim of this study is clear this relationship. Relevant literaure was searched from electronic databases. A meta-analysis was performed with elegible studies which quantitatively evaluated the relationship between EZH2 overexpression and survival of patients with colorectal cancer. Survival data were aggregated and quantitatively analyzed. We performed a meta-analysis of 8 studies (n = 1059 patients) that evaluated the correlation between EZH2 overexpression and survival in patients with colorectal cancer. Combined hazard ratios suggested that EZH2 overexpression was associated with better prognosis of overall survival (OS) HR(hazard ratio) = 0.61 95% CI (0.38–0.84) We performed bias analysis according Egger and Begg,s test and we did not find publication bias. EZH2 overexpression indicates a better prognosis for colorectal cancer.</jats:p> The role of EZH2 in overall survival of colorectal cancer: a meta-analysis Scientific Reports
doi_str_mv 10.1038/s41598-017-13670-z
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTEzNjcwLXo
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTEzNjcwLXo
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Springer Science and Business Media LLC, 2017
imprint_str_mv Springer Science and Business Media LLC, 2017
issn 2045-2322
issn_str_mv 2045-2322
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str viloriomarques2017theroleofezh2inoverallsurvivalofcolorectalcancerametaanalysis
publishDateSort 2017
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series Scientific Reports
source_id 49
title The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_unstemmed The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_full The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_fullStr The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_full_unstemmed The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_short The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_sort the role of ezh2 in overall survival of colorectal cancer: a meta-analysis
topic Multidisciplinary
url http://dx.doi.org/10.1038/s41598-017-13670-z
publishDate 2017
physical
description <jats:title>Abstract</jats:title><jats:p>Enhancer of zeste homolog 2 (EZH2) is the catalitic subunit of polycomb repressive complex 2 and mediates gene silencing. EZH2 is overexpressed in many cancers and correlates with poor prognosis. The role of the gene EZH2 in colorectal cancer survival is uncertainly, the aim of this study is clear this relationship. Relevant literaure was searched from electronic databases. A meta-analysis was performed with elegible studies which quantitatively evaluated the relationship between EZH2 overexpression and survival of patients with colorectal cancer. Survival data were aggregated and quantitatively analyzed. We performed a meta-analysis of 8 studies (n = 1059 patients) that evaluated the correlation between EZH2 overexpression and survival in patients with colorectal cancer. Combined hazard ratios suggested that EZH2 overexpression was associated with better prognosis of overall survival (OS) HR(hazard ratio) = 0.61 95% CI (0.38–0.84) We performed bias analysis according Egger and Begg,s test and we did not find publication bias. EZH2 overexpression indicates a better prognosis for colorectal cancer.</jats:p>
container_issue 1
container_start_page 0
container_title Scientific Reports
container_volume 7
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792342369720336388
geogr_code not assigned
last_indexed 2024-03-01T16:34:42.448Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+role+of+EZH2+in+overall+survival+of+colorectal+cancer%3A+a+meta-analysis&rft.date=2017-10-23&genre=article&issn=2045-2322&volume=7&issue=1&jtitle=Scientific+Reports&atitle=The+role+of+EZH2+in+overall+survival+of+colorectal+cancer%3A+a+meta-analysis&aulast=Molina&aufirst=Antonio+J.&rft_id=info%3Adoi%2F10.1038%2Fs41598-017-13670-z&rft.language%5B0%5D=eng
SOLR
_version_ 1792342369720336388
author Vilorio-Marqués, Laura, Martín, Vicente, Diez-Tascón, Cristina, González-Sevilla, María Francisca, Fernández-Villa, Tania, Honrado, Emiliano, Davila-Batista, Veronica, Molina, Antonio J.
author_facet Vilorio-Marqués, Laura, Martín, Vicente, Diez-Tascón, Cristina, González-Sevilla, María Francisca, Fernández-Villa, Tania, Honrado, Emiliano, Davila-Batista, Veronica, Molina, Antonio J., Vilorio-Marqués, Laura, Martín, Vicente, Diez-Tascón, Cristina, González-Sevilla, María Francisca, Fernández-Villa, Tania, Honrado, Emiliano, Davila-Batista, Veronica, Molina, Antonio J.
author_sort vilorio-marqués, laura
container_issue 1
container_start_page 0
container_title Scientific Reports
container_volume 7
description <jats:title>Abstract</jats:title><jats:p>Enhancer of zeste homolog 2 (EZH2) is the catalitic subunit of polycomb repressive complex 2 and mediates gene silencing. EZH2 is overexpressed in many cancers and correlates with poor prognosis. The role of the gene EZH2 in colorectal cancer survival is uncertainly, the aim of this study is clear this relationship. Relevant literaure was searched from electronic databases. A meta-analysis was performed with elegible studies which quantitatively evaluated the relationship between EZH2 overexpression and survival of patients with colorectal cancer. Survival data were aggregated and quantitatively analyzed. We performed a meta-analysis of 8 studies (n = 1059 patients) that evaluated the correlation between EZH2 overexpression and survival in patients with colorectal cancer. Combined hazard ratios suggested that EZH2 overexpression was associated with better prognosis of overall survival (OS) HR(hazard ratio) = 0.61 95% CI (0.38–0.84) We performed bias analysis according Egger and Begg,s test and we did not find publication bias. EZH2 overexpression indicates a better prognosis for colorectal cancer.</jats:p>
doi_str_mv 10.1038/s41598-017-13670-z
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE1OTgtMDE3LTEzNjcwLXo
imprint Springer Science and Business Media LLC, 2017
imprint_str_mv Springer Science and Business Media LLC, 2017
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 2045-2322
issn_str_mv 2045-2322
language English
last_indexed 2024-03-01T16:34:42.448Z
match_str viloriomarques2017theroleofezh2inoverallsurvivalofcolorectalcancerametaanalysis
mega_collection Springer Science and Business Media LLC (CrossRef)
physical
publishDate 2017
publishDateSort 2017
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series Scientific Reports
source_id 49
spelling Vilorio-Marqués, Laura Martín, Vicente Diez-Tascón, Cristina González-Sevilla, María Francisca Fernández-Villa, Tania Honrado, Emiliano Davila-Batista, Veronica Molina, Antonio J. 2045-2322 Springer Science and Business Media LLC Multidisciplinary http://dx.doi.org/10.1038/s41598-017-13670-z <jats:title>Abstract</jats:title><jats:p>Enhancer of zeste homolog 2 (EZH2) is the catalitic subunit of polycomb repressive complex 2 and mediates gene silencing. EZH2 is overexpressed in many cancers and correlates with poor prognosis. The role of the gene EZH2 in colorectal cancer survival is uncertainly, the aim of this study is clear this relationship. Relevant literaure was searched from electronic databases. A meta-analysis was performed with elegible studies which quantitatively evaluated the relationship between EZH2 overexpression and survival of patients with colorectal cancer. Survival data were aggregated and quantitatively analyzed. We performed a meta-analysis of 8 studies (n = 1059 patients) that evaluated the correlation between EZH2 overexpression and survival in patients with colorectal cancer. Combined hazard ratios suggested that EZH2 overexpression was associated with better prognosis of overall survival (OS) HR(hazard ratio) = 0.61 95% CI (0.38–0.84) We performed bias analysis according Egger and Begg,s test and we did not find publication bias. EZH2 overexpression indicates a better prognosis for colorectal cancer.</jats:p> The role of EZH2 in overall survival of colorectal cancer: a meta-analysis Scientific Reports
spellingShingle Vilorio-Marqués, Laura, Martín, Vicente, Diez-Tascón, Cristina, González-Sevilla, María Francisca, Fernández-Villa, Tania, Honrado, Emiliano, Davila-Batista, Veronica, Molina, Antonio J., Scientific Reports, The role of EZH2 in overall survival of colorectal cancer: a meta-analysis, Multidisciplinary
title The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_full The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_fullStr The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_full_unstemmed The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_short The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
title_sort the role of ezh2 in overall survival of colorectal cancer: a meta-analysis
title_unstemmed The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
topic Multidisciplinary
url http://dx.doi.org/10.1038/s41598-017-13670-z